Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1

ABSTRACT Dengue is the most prevalent arboviral disease afflicting humans, and a vaccine appears to be the most rational means of control. Dengue vaccine development is in a critical phase, with the first vaccine licensed in some countries where dengue is endemic but demonstrating insufficient effic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Heather Friberg, Luis J. Martinez, Leyi Lin, Jason M. Blaylock, Rafael A. De La Barrera, Alan L. Rothman, J. Robert Putnak, Kenneth H. Eckels, Stephen J. Thomas, Richard G. Jarman, Jeffrey R. Currier
Format: article
Langue:EN
Publié: American Society for Microbiology 2020
Sujets:
CMI
PIV
Accès en ligne:https://doaj.org/article/9a70ddf949f2464fbfa4032091e25a8f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!